Heron Therapeutics HRTX Balance Sheet (2010-2026)

NASDAQ HRTX
$0.34 -0.01 (-3.54%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Heron Therapeutics Quarterly Balance Sheet

Periods 64 quarters
Latest Jun 2026

Heron Therapeutics reported total assets of $252.26M and total liabilities of $245.35M for the quarter ended Jun 2026, up 8.7% year over year. This balance sheet covers 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
159.57M90.54M56.91M48.61M50.44M15.36M27.09M13.46M34.86M28.68M20.45M18.39M25.74M25.80M19.27M16.52M43.07M28.65M26.12M20.72M
Short-term InvestmentsInvestments (Current)
43.25M67.04M55.00M34.93M71.31M69.49M32.93M19.78M42.55M51.73M51.07M48.96M45.15M33.48M31.41M24.12M12.42M17.98M18.67M21.94M
Cash & Current Investments
202.82M157.58M111.91M83.54M121.75M84.85M60.02M33.24M77.41M80.41M71.52M67.35M70.89M59.28M50.68M40.63M55.49M46.63M44.78M42.66M
Receivables - NetNet Receivables
43.09M35.50M41.10M40.30M42.19M52.05M51.45M76.69M63.80M60.14M65.32M73.71M67.04M78.88M78.74M79.93M81.05M89.59M83.69M89.57M
Receivables - OtherOther Receivables
0.24M6.20M0.31M0.26M0.34M
Receivables
43.09M35.74M41.10M40.30M42.19M58.25M51.45M76.69M63.80M60.45M65.32M73.71M67.04M79.14M78.74M79.93M81.05M89.93M83.69M89.57M
Raw Materials
20.98M21.19M25.65M21.83M18.59M15.14M16.41M18.41M15.61M17.64M18.07M19.59M20.82M19.73M19.51M35.82M32.78M59.25M60.56M58.09M
Work In Process
11.55M20.93M13.30M20.11M11.62M20.72M17.91M9.02M16.42M14.55M16.29M16.05M18.35M27.19M28.95M26.14M26.34M26.61M21.62M24.27M
Finished Goods
8.97M6.25M17.52M19.37M22.03M18.71M17.74M17.19M9.97M9.92M8.11M7.22M6.78M6.24M8.47M11.00M10.90M6.88M10.36M8.22M
Inventory
41.50M48.38M56.47M61.32M52.24M54.57M52.06M44.62M42.01M42.11M42.47M42.86M45.95M53.16M56.93M72.97M70.03M92.75M92.54M90.58M
Prepaid Assets
27.64M12.96M13.11M9.05M7.63M13.96M14.63M10.72M10.77M6.12M6.58M7.25M11.31M17.69M26.49M17.39M22.84M9.10M7.97M7.03M
Current Assets
315.05M254.42M222.59M194.21M223.80M205.44M178.16M165.28M193.98M188.77M185.90M191.17M195.19M209.01M212.84M210.92M229.40M238.07M228.98M229.84M
Non-Current Assets
Construction in Progress
15.90M5.40M6.30M2.60M1.70M
Property, Plant & Equipment (Net)PP&E (Net)
22.79M23.73M23.86M23.47M22.62M22.16M21.51M20.87M20.79M20.17M19.31M15.90M15.41M14.86M14.54M13.68M12.96M12.40M12.03M11.81M
Long-Term Deferred Tax
Other Non-Current Assets
0.35M17.72M17.98M17.53M17.32M15.71M14.14M8.58M8.37M8.13M7.88M6.93M6.71M6.48M6.28M6.08M5.88M5.41M5.21M5.01M
Non-Current Assets
37.34M51.28M51.13M49.76M48.15M45.52M42.72M35.94M35.22M33.73M31.98M26.97M25.59M24.13M22.91M21.17M19.55M17.81M17.23M22.42M
Assets
352.39M305.71M273.72M243.97M271.95M250.95M220.88M201.22M229.20M222.51M217.89M218.14M220.78M233.15M235.75M232.09M248.95M255.88M246.22M252.26M
Liabilities
Current Liabilities
Accounts Payables
5.88M3.80M8.23M13.80M6.55M3.23M4.07M1.96M1.86M3.24M0.84M10.23M10.19M11.71M12.33M12.04M12.02M8.99M8.97M11.64M
Notes Payables
149.81M
Payables
5.88M3.80M8.23M13.80M6.55M3.23M4.07M1.96M1.86M3.24M0.84M10.23M10.19M11.71M12.33M161.84M12.02M8.99M8.97M11.64M
Accumulated Expenses
16.01M15.26M12.21M16.32M14.71M13.42M9.51M9.86M10.38M9.22M7.65M7.08M8.53M9.55M6.45M6.47M8.75M9.27M6.39M6.63M
Other Accumulated Expenses
30.00M25.86M32.80M33.15M32.70M38.55M40.29M52.45M39.77M41.85M43.81M42.26M40.72M41.76M47.42M46.22M48.50M51.24M49.99M51.49M
Current Leases
3.25M2.42M2.48M2.55M2.62M2.69M2.76M2.58M3.00M3.08M3.14M3.19M3.25M3.04M2.29M1.54M0.78M0.20M
Current Deferred Revenue
Total Current Liabilities
72.30M71.06M93.00M109.50M93.88M82.36M77.90M86.72M79.75M79.69M75.38M80.32M85.54M91.46M88.56M258.60M89.71M96.10M90.52M92.14M
Non-Current Liabilities
Non-Current Debt
24.02M24.26M24.45M24.63M24.83M25.03M25.21M107.49M107.90M108.31M108.72M
Convertible Debt
149.03M149.08M149.13M149.18M149.23M149.28M149.34M149.39M149.44M149.49M149.54M149.59M149.65M149.70M149.75M32.18M32.74M33.33M33.92M
Non-Current Deffered Revenue
Operating Leases
12.22M8.00M7.39M6.78M6.15M5.50M4.83M4.16M3.54M2.80M2.04M1.29M0.52M1.54M0.78M5.50M
Other Non-Current Liabilities
0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.24M0.61M0.68M0.75M4.69M4.81M4.93M5.05M
Total Non-Current Liabilities
249.52M265.46M249.26M237.14M232.07M240.27M256.74M256.24M251.41M255.84M260.54M266.18M263.52M258.60M229.37M236.74M232.15M240.30M
Total Liabilities
233.54M228.14M249.76M265.70M249.50M237.38M232.31M240.51M256.99M256.48M251.65M256.08M260.78M266.80M264.20M259.35M234.06M241.54M237.08M245.35M
Shareholder's Equity
Total Debt
24.02M24.26M24.45M24.63M24.83M25.03M25.21M149.81M107.49M107.90M108.31M108.72M
Common Equity
118.84M77.57M23.96M-21.74M22.45M13.57M-11.43M-39.28M-27.79M-33.97M-33.77M-37.94M-40.01M-33.65M-28.45M-27.26M14.88M14.33M9.14M6.91M
Liabilities and Shareholders Equity
352.39M305.71M273.72M243.97M271.95M250.95M220.88M201.22M229.20M222.51M217.89M218.14M220.78M233.15M235.75M232.09M248.95M255.88M246.22M252.26M
Retained Earnings
1,676.61M1,689.99M1,700.26M-1733.68M1,796.90M1,807.86M-1828.22M-1870.28M-1895.29M-1906.01M-1909.17M-1918.41M-1923.26M-1919.59M-1916.96M-1919.34M1,942.03M1,951.18M1,954.11M1,957.36M
Preferred Shares
7.86M1.05M1.05M1.05M